Projected Price to Earnings: GlucoTrack (GCTK)

GCTK (GlucoTrack) - company brandmark

GlucoTrack, Inc. (GCTK) is developing high-tech intravascular biosensors as it prepares for large-scale clinical trials. The company's valuation based on forward P/E, with GURU.Markets data illustrated on this chart, confirms growth potential, while 0.00 serves as the current parameter value. Stable revenue is driven by user loyalty to non-invasive monitoring systems. An ecological approach and transparent component procurement management complete the foundation for sustainable business development.

glucotrack.com - GCTK Market Cap to Future Earnings Ratio (period 04/28/2023 - 10/31/2026)

Metric breakdowns and analytics for glucotrack.com (GCTK)

- stock quotes and analyst forecast:
Stock Price GlucoTrack, Inc.|GCTK - Average Forecast Price
- company stock exchange capitalization indicators:
Market Valuation GlucoTrack Inc.|GCTK - Enterprise Value
- issuer book value statistics:
Accounting Value per Share GlucoTrack|GCTK - Total Net Assets|Market Capitalization to Book Value Ratio glucotrack.com|GCTK - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital GlucoTrack, Inc.|GCTK - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio GlucoTrack|GCTK - Aggregate Debt Obligations|Debt to Book Capitalization Ratio GlucoTrack Inc.|GCTK - Company Long-Term Liabilities|Company Short-Term Debts GlucoTrack|Quick Ratio glucotrack.com
- financial results and valuation multiples details:
GCTK - Company Profit|Projected Future Earnings GlucoTrack, Inc.|GCTK - Business Payback Period|Forward P/E Multiple GlucoTrack, Inc.|GCTK - Price/Earnings to Growth Multiple|EV/EBITDA Multiple GlucoTrack Inc.|GCTK - Operating profit EBITDA|Earnings per share for the last twelve months GlucoTrack|GCTK - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months glucotrack.com|GCTK - Earnings per share increase in current year|Earnings growth forecast for next year GlucoTrack, Inc.
Fundamental valuation:GCTK GlucoTrack, Inc.
Brand item of GlucoTrack Inc.

This metric is calculated as the ratio of the current market share price to the projected earnings per share, determining the investment payback period based on future cash flows. For GlucoTrack, Inc. (GCTK), which focuses on R&D for implantable sensors without an M&A strategy, the issuer's forward P/E on GURU.Markets serves as an indicator of the extent to which the market has priced in the success of the future commercialization of its medical developments.

Competitors of GlucoTrack, Inc.

Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (InMode Corp) - Forward P/E Multiple|Projected Price to Earnings Picard Group (PMI)|Projected Price to Earnings SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Outset Medical Corp|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical) - Forward P/E Multiple|Profound Medical Corporation (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings edap-tms.com EDAP|Forward P/E Multiple APYX (Apyx Medical Corporation)|Forward P/E Multiple IceCure Medical Ltd. ICCM|LUNG - Future Price to Earnings|TELA: Future Price to Earnings|CTSO (cytosorbents.com) - Projected Price to Earnings|Sensus - Future Price to Earnings Multiple|ZYXI (Zynex, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio electroCore Medical ECOR|Future Price to Earnings Vicarious Surgical Inc. (RBOT)|inspira-technologies.com (IINN) - Forward Price to Earnings Multiple|SeaStar Medical Holding Corp - Projected Price to Earnings|Forward P/E Multiple IRIDEX Corp IRIX|Intelligent Bio - Forward P/E Multiple|Market Cap to Projected Earnings Beyond Air, Inc. XAIR|Profusa (PFSA) - Future Price to Earnings|Price to Expected Earnings Ratio SSKN (STRATA Skin Sciences, Inc.)|Future Price to Earnings NanoVibronix|Projected Price to Earnings Venus Concept Corporation (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|KNW: Forward P/E Multiple|Forward Price to Earnings Multiple inarimedical.com NARI|Future Price to Earnings Nevro|Future Price to Earnings RSLS|Projected Price to Earnings SILK (Silk Road Medical Inc.)